Marotta, F. et al. 2013. A sturgeon-derived bioactive compound beneficially modulates nuclear receptors controlling metabolic functions in patients with metabolic syndrome. Acta Biomedica Atenei Parmensis. 84, 1 (Jun. 2013), 53–60.